You have 9 free searches left this month | for more free features.

risankizumab

Showing 1 - 25 of 70

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Crohn's Disease Trial (Risankizumab SC, Placebo for risankizumab)

Not yet recruiting
  • Crohn's Disease
  • Risankizumab SC
  • Placebo for risankizumab
  • (no location specified)
Sep 26, 2023

Genital Psoriasis, Scalp Psoriasis Trial (Risankizumab, Placebo for Risankizumab)

Not yet recruiting
  • Genital Psoriasis
  • Scalp Psoriasis
  • Risankizumab
  • Placebo for Risankizumab
  • (no location specified)
Jul 24, 2023

Healthy Volunteers Trial (Risankizumab)

Not yet recruiting
  • Healthy Volunteers
  • Risankizumab
  • (no location specified)
Sep 20, 2023

Crohn's Disease Trial (Risankizumab)

Not yet recruiting
  • Crohn's Disease
  • Risankizumab
  • (no location specified)
Aug 10, 2023

Juvenile Psoriatic Arthritis Trial (Adalimumab, Risankizumab)

Not yet recruiting
  • Juvenile Psoriatic Arthritis
  • (no location specified)
Oct 20, 2023

Healthy Volunteers Trial in United States (Risankizumab Dose A, Risankizumab Dose B)

Active, not recruiting
  • Healthy Volunteers
  • Risankizumab Dose A
  • Risankizumab Dose B
  • Anaheim, California
  • +4 more
Jan 12, 2023

Assess Adverse Events When Subcutaneous Risankizumab Injection

Withdrawn
  • Psoriasis
  • Risankizumab
  • +2 more
  • (no location specified)
Dec 8, 2022

Psoriasis Vulgaris Trial in Belgium (Venapuncture, Patient questionnaires)

Recruiting
  • Psoriasis Vulgaris
  • Venapuncture
  • Patient questionnaires
  • Ghent, East-Flanders, Belgium
  • +6 more
Jan 5, 2023

Psoriasis Trial in Portland (risankizumab)

Active, not recruiting
  • Psoriasis
  • risankizumab
  • Portland, Oregon
    Oregon Medical Research Center
Aug 15, 2022

Risankizumab Exposed Pregnancies Relative to Those

Recruiting
  • Psoriasis
  • Morrisville, North Carolina
  • +1 more
May 31, 2022

Arthritis, Psoriatic, Healthy Trial in Graz (Guselkumab, Risankizumab)

Terminated
  • Arthritis, Psoriatic
  • Healthy
  • Graz, Austria
    Medical University Graz
Jul 22, 2022

Assess Participant-Reported Real-World Experience of

Recruiting
  • Crohn's Disease
    • London, London, City Of, United Kingdom
      Guys and St Thomas NHS Foundation Trust /ID# 258986
    Nov 7, 2023

    Healthy Volunteers Trial in Grayslake, Austin (Risankizumab)

    Completed
    • Healthy Volunteers
    • Risankizumab
    • Grayslake, Illinois
    • +1 more
    Mar 9, 2022

    Healthy Volunteers Trial in Shanghai (Risankizumab)

    Completed
    • Healthy Volunteers
    • Risankizumab
    • Shanghai, Shanghai, China
      Shanghai Xuhui Central Hospital /ID# 212830
    Mar 3, 2022

    Healthy Volunteers Trial in Grayslake (risankizumab)

    Completed
    • Healthy Volunteers
    • risankizumab
    • Grayslake, Illinois
      Acpru /Id# 165737
    Mar 9, 2022

    Healthy Volunteers Trial in Cypress (Risankizumab, Placebo)

    Completed
    • Healthy Volunteers
    • Risankizumab
    • Placebo
    • Cypress, California
      Altasciences Clinical Los Angeles, Inc /ID# 164197
    Mar 23, 2022

    Healthy Volunteers Trial in United States (Risankizumab)

    Completed
    • Healthy Volunteers
    • Risankizumab
    • Anaheim, California
    • +7 more
    Mar 8, 2022

    Healthy Volunteers Trial in Grayslake (Risankizumab)

    Completed
    • Healthy Volunteers
    • Risankizumab
    • Grayslake, Illinois
      Acpru /Id# 223662
    Mar 8, 2022

    Ulcerative Colitis (UC), Crohn's Disease Trial in Germany, Israel, United States (Risankizumab, Cytochrome P450 (CYP)

    Completed
    • Ulcerative Colitis (UC)
    • Crohn's Disease
    • Risankizumab
    • Cytochrome P450 (CYP) Substrates
    • Coronado, California
    • +5 more
    Oct 20, 2022

    Disease Symptoms in Adult Moderate to Severe Psoriasis Treated

    Recruiting
    • Psoriasis
      • Beer Sheva, HaDarom, Israel
      • +7 more
      Aug 3, 2022

      Psoriasis Trial (risankizumab, for risankizumab, ustekinumab)

      Completed
      • Psoriasis
      • risankizumab
      • +3 more
      • (no location specified)
      Jul 28, 2021

      Psoriasis Trial (risankizumab, adalimumab, for risankizumab)

      Completed
      • Psoriasis
      • risankizumab
      • +3 more
      • (no location specified)
      Jul 28, 2021

      Disease State When Subcutaneous Risankizumab Injection is Given

      Recruiting
      • Psoriasis
        • Taichung City, Taiwan
        • +1 more
        May 19, 2022

        Psoriasis Trial in Japan (risankizumab)

        Completed
        • Psoriasis
        • risankizumab
        • Nagoya-shi, Aichi, Japan
        • +8 more
        Nov 16, 2021